News & Events

AllCells-Shanghai is now situated in Ju Ke Park (聚科生物园区) near the center of the city with almost 10,000 sq. ft of laboratory, production and office space. The new facility is also equipped with GMP level cell culture rooms. AllCells’ Chief Executive, Jay Tong, MD commented, “The Ju Ke Biotechnology Park location not only provides the larger space that is essential for supporting the company’s continuing growth, but also enables us have access to better and highly controlled bio-processing environments. This is a really important consideration for producing high quality primary cell products, tissues, and services that our customers depend upon for their biomedical applications.”

AllCells-Shanghai is currently recruiting individuals to fill several open positions in the areas of Sales & Marketing / Business Development, Production, and Operations Management. Refer to the Careers section of www.AllCells.com for more information.


About AllCells, LLC

AllCells (www.AllCells.com) is a global biotechnology company founded in 1998 to provide researchers with a reliable supply of biologically relevant, consistent quality primary cells that enable the advancement of scientific research in the areas of cell biology, oncology, virology, hematology, infectious disease and stem cell research. Unlike cell lines, which are typically mutated, transformed or immortalized, primary cells retain their original phenotypes hence better reflect in vivo morphology, metabolism and growth characteristics. These attributes are especially important for in vitro research applications where in vivo-like models are critically important. By partnering with AllCells, investigators can dramatically reduce time needed to isolate cells with guaranteed consistency thereby improving the efficiency, accuracy and relevance of their research studies. AllCells is fully certified in accordance with local, state and federal requirements.

AllCells-Shanghai facilities produce animal derived primary cell types including bone marrow mononuclear cells, stromal cells, immunological, splenocytes, pancreatic islets, neural system (astrocytes, meningeal cells), and others. The company’s products are used in routine cell-based assays for compound screening, predictive toxicology, and other research applications that enable pre-clinical drug development. Additionally, the company plans to expand its service offering to include hematopoietic stem cell expansion & differentiation, flow-cytometry services (e.g. comprehensive FACS analysis, up to 11 colors), immunophenotyping, in-vitro characterization of malignant cells (e.g. leukemia, myeloma, lymphoma, etc.), custom cell-based assays, and validation studies involving cell/tissue separation devices for laboratory or clinical use by importing AllCells-USA made human primary cells.

Emeryville, CA (June 29, 2011) – AllCells, LLC (the “company”) announced that it has been certified as both a Minority Owned Business Enterprise (MBE) and a Small Business (SB). 

The company has been granted MBE status by both the Northern California Minority Supplier District Council (NCMSDC) and The Supplier Clearinghouse.  Additionally, AllCells is certified as a Small Business with the State of California Office of Small Business and DVBE Services.  (Read More here)

EMERYVILLE, Calif.--(BUSINESS WIRE)--AllCells, LLC, a leading global provider of human hematopoietic primary cells and related services has been ranked among the top 50 fastest growing Asian-American businesses by the Washington DC-based US Pan Asian American Chamber of Commerce Education Foundation (USPAACC).View full release.

Download our 2011-2012 Product Catalog as a PDF.

AllCells will be exhibiting at the upcoming Molecular Med Tri-Con 2011 (February 23-25) meeting taking place at the San Francisco Moscone Convention Center. For more information about the meeting, go to www.triconference.com

AllCells, LLC, a leading global provider of human primary cells and related services has announced an expanded range of primary adult stem cell products for in-vitro research use. A total of fifteen (15) new primary stem cell products are now available within the areas of Dental Mesenchymal stem cells, Cord Blood stem cells, Amniotic stem cells, and Placental stem cells. Read more here.

AllCells will be exhibiting at the upcoming American Society of Hematology Annual Meeting. Read more here.

AllCells is pleased to announce we will be attending the American Society of Hematology annual meeting, taking place in Orlando, FL in December. Visit our booth (#1365) for your chance to win a prize! More details will be revealed in the coming months. For more information on the American Society of Hematology, please visit www.hematology.org

AllCells will enlighten conference attendees with information about their stem cell products and services at the 8th annual ISSCR meeting. Read more here.

AllCells is pleased to announce our attendance in the 2010 ISSCR conference in San Francisco, CA. During the ISSCR, we will be higlighting our products and services to our stem cell research community. Visit us at booth #317. For more information regarding the ISSCR, please visit www.isscr.org

AllCells, stem cell distributor and progenitor provider, carries cells for blood related disease research. Visit www.allcells.com or call 1-888-535-3444. Read more here.

AllCells is pleased to announce our attendance at the 2010 American Association of Immunologists conference in Baltimore, MD. During the AAI, we will be higlighting our products and services to our cancer research community. We will be exhibit in booth #1203. For more information regarding the AAI, please visit www.aai.org